期刊文献+

大肝癌TACE后肿瘤组织VEGF、αv整合素表达及MVD变化 被引量:5

Expression of VEGF,integrin-αV and MVD in viable residual tumor tissues from large hepatocellular carcinoma after TACE
下载PDF
导出
摘要 目的观察大肝癌经导管动脉化疗栓塞(TACE)后残存肿瘤组织血管内皮生长因子(VEGF)、αv整合素表达及微血管密度(MVD)变化的意义。方法 96例大肝癌前瞻性分成术前TA-CE组40例(TACE组)与一期手术组56例(手术组),用免疫组化方法检测96例手术切除标本肿瘤组织VEGF、αv整合素表达及MVD值。结果术前TACE组肿瘤组织VEGF、αv整合素表达免疫反应积分显著高于手术组(分别为P=0.042,P=0.033),MVD两者无显著差异(P=0.103)。结论大肝癌术前TACE促使残存肿瘤组织VEGF及αv整合素的表达增高,有可能促进肿瘤细胞转移。 Objective To investigate the significance of expression of vascular endothelial growth factor(VEGF),integrin-αV and microvessel density(MVD)in viable residual tumor tissues from large hepatocellular carcinoma(HCC) after transcatheter arterial chemoembolization(TACE).Methods 96 patients with large HCC were divided to a preoperative TACE group(40 patients) and one-stage operation group(56 patients).Expression of VEGF,integrin-αV and MVD were examined in all viable residual tumor tissues of 96 patients using immunohistochemical staining.Results There were significant differences in the expression levels of VEGF and integrin-αV between preoperative TACE group and one-stage operation group(P=0.042 and P=0.033).No significant difference was in MVD between two groups (P=0.103).Conclusion TACE may enhance expression levels of VEGF and integrin-αV in viable residual tumor tissues from large HCC,and may promote cancer cells to metastasize.
出处 《东南国防医药》 2010年第3期206-208,共3页 Military Medical Journal of Southeast China
关键词 肝细胞癌 化疗栓塞 血管内皮生长因子 整合素 微血管密度 hepatocellular carcinoma chemoembolization vascular endothelial growth factor Iintegrin microvessel density
  • 相关文献

参考文献9

  • 1肖恩华,胡国栋,李锦清,黄洁夫.经导管动脉化疗栓塞治疗肝细胞癌的疗效观察[J].中华肿瘤杂志,2005,27(8):478-482. 被引量:21
  • 2Zhou WP, Lai EC, Li A J, et al. A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma [ J ]. Ann Surg , 2009,249 (2) :195-202.
  • 3Cristofori C, Cardin R, Pivetta G, et al. Transcatheter arterial chemoembolization ( TACE ) in hepatocellular carcinoma ( HCC ) : the role of angiogenesis and invasiveness [ J ]. Am J Gastroenterol, 2008,103 (4) :914-921.
  • 4Poon RT, Ronnie TP. From molecular biology to targeted for hepatocellular carcinoma: the future is now [ J ]. Oncology, 2007,72 (1) :30-44.
  • 5Park JW, Lee JA, Park JE, et al. Association between vascular endothelial growth factor gene polymorphisms and survival in hepatocellular carcinoma patients [ J ] . Hepatology, 2007,46 ( 2 ) : 446- 455.
  • 6Chen QM, Millar H J, McCabe FL, et al. Alphav integrin-targeted immunoconjugates regress established human tumors in xenograft models [ J ]. Clin Cancer Res, 2007,13 ( 12 ) : 3689-3695.
  • 7Mimoun N, Zakia H, Geraldine G, et al. Expression, Regulation, and Function of αv integrins in hepatocellular carcinoma:An in vivo and in vitro study[ J]. Hepatology,2002,36(2) :418-426.
  • 8Kim HJ,Chung H,Yoo YG, et al. Inhibitor of DNA binding 1 actvates vascular endothelial growth factor through enhancing the stability and activity of hypoxia-inducible factor-1 alpha [ J ]. Mol Cancer Res,2007,5 (4) :321-329.
  • 9Tai MH, Huang CC, Wang CC, et al. Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma(HCC) and adverse outcome of HCC patients[ J ]. J Surg Oncol, 2008,98 ( 5 ) : 349 -357.

二级参考文献6

共引文献20

同被引文献62

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部